ADM Diagnostics, Inc.
Northbrook, IL
- UEI
- RM7GK4PLCXK9
- CAGE
- 5XWA1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 555 Skokie Blvd, Northbrook, IL 60062, USA
- Website
- admdx.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 89 Services, Not Elsewhere Classified
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of Arizona | R01AG075122 | $473,547 | |
| University Of Arizona | R01AG063826 | $769,363 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Donald S. Marks, M.D P.C | Plymouth, MA | — |
| National Clinical Research, Inc. | Richmond, VA | 813212 Voluntary Health Organizations |
| Gonzalez M.D & Aswad M.D Health Services Corp | Miami, FL | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Acepre, LLC | Columbia, SC | 325412 Pharmaceutical Preparation Manufacturing |
| Research And Development | San Diego, CA | — |
About the company
ADM Diagnostics, Inc. is a for-profit corporate entity that has been registered in SAM.gov since 2010. While general background information is not provided, the entity appears to specialize in providing products or services related to clinical trials and medical research.
ADM Diagnostics, Inc. has received several sub-federal grant awards from the University of Arizona to conduct clinical trials related to neurological conditions and women's health. Specifically, it has been involved in a double-blind, randomized, placebo-controlled Phase 2 clinical trial studying the efficacy of a product called PHYTOSERM in preventing menopause-associated decline in brain metabolism and cognition. Additionally, it has been awarded a sub-grant from the University of Arizona to conduct a Phase 2 clinical trial investigating the use of allopregnanolone as a regenerative therapeutic for Alzheimer's disease. These grant awards suggest that ADM Diagnostics, Inc. provides services related to the design, implementation, and management of clinical trials for medical products and treatments, potentially in the areas of neurology, women's health, and Alzheimer's research.
Quick answers
Is ADM Diagnostics, Inc. registered in SAM.gov?
Yes. ADM Diagnostics, Inc.'s SAM.gov registration is active through July 27, 2027.
What is ADM Diagnostics, Inc.'s most recent federal award?
ADM Diagnostics, Inc.'s most recent federal grant award is Multi-modal machine learning detection and tracking of traumatic brain injury neurodegeneration and its differentiation… (R44AG060861), from National Institute on Aging (NIH), on September 30, 2018.
On GovTribe
See ADM Diagnostics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors